Physician profile
David J Koster
NPI 1063406163
$459.61
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $294 · 2020: $35.31 · 2021: $30.23 · 2022: $84.87 · 2023: $15.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $69.42 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $55.28 | 2019 | |
| Amgen INC. | $45.21 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $40.97 | 2019 | |
| Novartis Pharmaceuticals Corporation | $34.32 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $30.51 | 2019 | |
| Morphosys, US INC. | $25.00 | 2022 | |
| Tesaro, INC. | $24.27 | 2019 | |
| Emd Serono, INC. | $23.47 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.33 | 2019 | |
| Pfizer INC. | $16.08 | 2019 | |
| Celgene Corporation | $15.14 | 2023 | |
| Lilly USA, LLC | $15.13 | 2019 | |
| Seqirus USA INC | $13.73 | 2022 | |
| Gilead Sciences, INC. | $11.92 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Masimo Corporation | $11.60 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $11.23 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Koster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.